GMPS


Summary: In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in GMPS


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IBA GO:0003824 catalytic activity
MF EXP GO:0003921 GMP synthase activity
MF IBA GO:0003921 GMP synthase activity
MF IBA GO:0003922 GMP synthase (glutamine-hydrolyzing) activity
MF IEA GO:0005524 ATP binding
MF IEA GO:0016462 pyrophosphatase activity
Showing 1 to 6 of 14 rows rows per page

Gene expression in normal tissue: GMPS

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in GMPS


Loading, please wait...
Database
Pathway ID
Pathway Des.
pharmgkb PA2040 Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics
kegg hsa00230 Purine metabolism - Homo sapiens (human)
kegg hsa00983 Drug metabolism - other enzymes - Homo sapiens (human)
humancyc PWY-7221 guanosine ribonucleotides de novo biosynthesis
humancyc PWY-7228 guanosine nucleotides de novo biosynthesis
humancyc PWY-841 purine nucleotides de novo biosynthesis
Showing 1 to 6 of 35 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD263 AACOCF3 3
iGMDRD188 Piperlongumine 3
iGMDRD398 Sepantronium 3
iGMDRD506 Fedratinib 1
Showing 1 to 4 of 18 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in GMPS

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​